If you enjoyed the #AACR24 Major Symposium on Engineering strategies based on NK and gd T cells, be sure to check out this paper on the topic.
bit.ly/3JcD50j AACR

Congratulations to the recipient of the Cancer Immunology Research Award for Outstanding Journal Article, Steven A. Rosenberg, for work on TCR–engineered T cells targeting mutant p53.
bit.ly/4cUnsIw
Sri Krishna Frank Noam Stephanie L Goff, MD, FACS Anup Parikh, MD #AACR24 AACR

Don't miss this recent paper evaluating dysbiosis and #melanoma response to anti-PD-1 related to the #AACR24 session on the tumor microbiome.
bit.ly/3TQSTuU AACR

Before the #AACR24 session on 'Understanding the Mechanisms of Resistance to Immunotherapeutic Approaches in #MultipleMyeloma ,' check out this paper on the effectiveness of DCAR as an alternate therapy for #mmsm :
bit.ly/4aAlyvq

Attending the #AACR24 mini-symposium 'New Insights for Therapies Modulating Antitumor T-Cell Responses'? Don’t miss the article on the use of machine learning to illuminate the impact of anti-CD40 on T cells.
bit.ly/3TUWsQu
LisaCoussens@CoussensLab @OHSUPancreatic

Attending #AACR24 ? Pick up a copy of the AACR Journals Collection, Immunotherapy, at the Publications Booth 4043 during the AACR Annual Meeting 2024.
bit.ly/4av7NxS

This episode of Inside Cancer Careers discusses the mission of BlackinCancer, which aims to increase the number of Black cancer researchers, provide visibility, and bring awareness about cancer to the community. spr.ly/6015wKU3x #InsideCancerCareers #CancerWorkforce

Attending the Major Symposium 'The Microbiome and Treatment Response to Cancer Therapy,' at #AACR24 ? Read the recent paper with session chair Marcel van den Brink as a coauthor.
bit.ly/3TUTvzs
Arielle Elkrief, MD FRCPC Jonathan (Tsoni) Peled

Out now with the #AACR24 poster session PO.CL06.10:
Unleashing Natural IL18 Activity Using An Anti-IL18BP Blocker Induces Potent Immune Stimulation And Antitumor Effects, by Menachem and Alteber et al.
bit.ly/49shRq1
Compugen Ltd

Read the new article by first author Jiuling Yang, published simultaneously at #AACR24 —
PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.
aacrjournals.org/cancerimmunolr…
UC San Francisco UC San Franciscostemcell UC San FranciscoUrology UC San FranciscoCancer AACR

Read the article by the recipients of the Cancer Immunology Research Award for Outstanding Journal Article, Steven A. Rosenberg et al.—
T-cell Therapy Targeting p53 Neoantigens in Solid Tumors.
doi.org/10.1158/2326-6…
AACR #AACR24

Congratulations to Steven A. Rosenberg, MD, PhD, and colleagues, recipients of the inaugural Cancer Immunology Research Award for Outstanding Journal Article! Learn more about this award:
bit.ly/3vViTgt
National Cancer Institute NCI Center for Cancer Research AACR #AACR24

Attending the #AACR24 AACR-Cancer Research Institute Lloyd J. Old Award in Cancer Immunology Award Lecture, by Gordon Freeman? Read his work identifying KIR3DL3 as an inhibitory receptor for HHLA2.
bit.ly/4ar8Rmu
Alyssa Klee

Out now with the #AACR24 late-breaking session LBMS01:
PVRL2 Suppresses Antitumor Immunity Through PVRIG- and TIGIT-Independent Pathways, by Robert Blelloch, Jiuling Yang et al.
bit.ly/4cMqT46
UC San Francisco UC San Franciscostemcell UC San FranciscoUrology UC San FranciscoCancer AACR

Don't miss the article 'Associations of intragenic rearrangement burden with immune cell infiltration and response to immune checkpoint blockade in cancer,' related to poster 3861/22 in #AACR24 session PO.CL06.04.
bit.ly/3JbleXS
UPMC Hillman Cancer Center AACR

👉How do you improve the only FDA approved cellular therapy for #prostatecancer ?

✅out our newest work in Cancer Immunology Research #AACR24

👉First deep analysis of Sip-T & est'd preclinical model. thx 2 Brian Van Tine Fehniger Lab Pachynski Lab

aacrjournals.org/cancerimmunolr…

Thanks Elise AlspachLab for a great start to my #AACR24 , exciting to hear how much we are learning about sex-based differences in antitumor immunity. Read more in her recent Cancer Immunology Research review doi.org/10.1158/2326-6…

Our review “CD4+ Regulatory T Cells in Human Cancer: Subsets, Origin, and Molecular Regulation” is out Cancer Immunology Research aacrjournals.org/cancerimmunolr…. We discuss Treg heterogeneity in cancer with focus on CCR8+ Tregs Cancer Research Institute

Functional, expanded T cells may be responsible for #ICB success in classical Hodgkin lymphoma according to new research in Cancer Immunology Research from Kline Lab and team. UChicago Medicine University of Chicago Hematology/Oncology #cHL #lymsm
ow.ly/KZSO50R9och

Work from a large group of friends and investigators in prostate cancer led by super star Atish Choudhury, MD PhD from Dana-Farber Lank Center for Genitourinary Oncology

Cancer Immunology Research AACR